Clinical trial
Efficacy of Combination Therapy for Prevention of Effects of Malaria During…
NCT00164255 · Centers for Disease Control and Prevention, U.S. Fed · Completed
Key facts
| NCT number | NCT00164255 |
|---|---|
| Title | Efficacy of Combination Therapy for Prevention of Effects of Malaria During Pregnancy |
| Official title | Efficacy of Intermittent Sulfadoxine-Pyrimethamine and Sulfadoxine-Pyrimethamine + Artesunate Treatment in the Prevention of Malaria in Pregnancy in an Area With Chloroquine-Resistant Plasmodium Falciparum |
| Lead sponsor | Centers for Disease Control and Prevention, U.S. Fed |
| Collaborators | Ifakara Health Research and Development Centre |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Malaria |
| Intervention type | Drug |
| Interventions | sulfadoxine/pyrimethamine, sulfadoxine/pyrimethamine plus artesunate |
| Enrollment | 1,614 |
| Start date | Jan 1, 2003 |
| Primary completion | Jun 1, 2009 |
| Completion | Jun 1, 2009 |
| First posted | Sep 14, 2005 |
| Last update posted | Sep 11, 2012 |
| Countries | Tanzania |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: